# ThunderBio Life Science

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thunderbio-life-science

- Industry: Medical Devices & Equipment
- Headquarters: Jiaxing, China
- Website: www.thunder-bio.com
- Latest round: Series B (Oct 10, 2025)
- Investors on record: 9

## About

Established in 2018 and based in Jiaxing, China, ThunderBio Life Science is an in-vitro testing equipment developer, providing digital liquid biopsy technology. The company has research and development centers in Shenzhen, Jiaxing and Hong Kong. Its core team has working experience in the development of microfluidic chips, instruments and reagents. The founder and CEO of the company, Guohui Zhou graduated from Hong Kong University. ThunderBio Life Science has launched the galaxy single cell lsolator in 2020 and comet droplet sorter in 2021. In October 2025, ThunderBio Life Science closed a series B2 funding from new investor Shanghai STVC Group.

The company has self-developed and production technology platform include digital PCR (polymerase chain reaction) system, single cell sequencing system, screening system. The company's main products has droplet reader, generator, droplet PCR AIO, droplet microfluidic sorter, and amplification reagents. Its products are used in cancer research, early cancer screening, targeted therapies and antibody screening. The company also provides life science solutions for microfluidic chips, instruments and reagents.

The company will commercialize droplet microfluidic and build a life science instrument tool platform.

## Funding rounds

- Series B, Oct 10, 2025 — Shanghai STVC Group
- Series B, Jan 4, 2024 — Shandong High-tech Investment Corporation, Jinkong Fund Management, BridgeOne Capital, Zip Capital, Shenzhen Chenmuyun Technology
- Series A, Aug 30, 2021 — Detong Capital, Juffett Capital, Shenzhen Xinzheng Asset Management

## Investors

- Detong Capital (https://capitalatlas.ai/funds/detong-capital) — Series A
- Juffett Capital (https://capitalatlas.ai/funds/juffett-capital) — Series A
- Shenzhen Xinzheng Asset Management — Series A
- Shandong High-tech Investment Corporation (https://capitalatlas.ai/funds/shandong-high-tech-investment-corporation) — Series B
- Jinkong Fund Management (https://capitalatlas.ai/funds/jinkong-fund-management) — Series B
- BridgeOne Capital (https://capitalatlas.ai/funds/bridgeone-capital) — Series B
- Zip Capital (https://capitalatlas.ai/funds/zip-capital) — Series B
- Shenzhen Chenmuyun Technology — Series B
- Shanghai STVC Group (https://capitalatlas.ai/funds/shanghai-stvc-group) — Series B